Skip to main content

The Psychedelic Renaissance - Futures 2022

Futures 2022 - Psychedelic Renaissance

Where? Totnes Cinema, Totnes

Where? 7.30pm, Thursday 20 October

Psychedelic drugs are gaining popularity in the pharmaceutical industry because of their benefits for people suffering with psychiatric disorders. 

Groundbreaking work at Imperial College suggests that psilocybin in Magic Mushrooms ‘resets’ brain activity in people with depression, while MDMA may help those with PTSD. 

What are the potential benefits and drawbacks?

The Philosophy and Psychedelics Exeter Research Group aims to advance philosophical scholarship and debate on psychedelic experiences, substances, and their wider societal setting. The group’s founders will speak.

Join a trip with world experts David Nutt, Dr David Erritzoe, Professor Christine Hauskeller, Dr Peter Sjöstedt-Hughes, and BBC host Ritula Shah to look at the medical, societal, and historical implications of these recent discoveries.

Come along to make questions and comments and join the conversation - or just sit and listen!

About the researchers

Christine is a philosopher with training in sociology and psychology also. Her research interests include a range of topics in Moral Philosophy and Empirical Ethics, Feminist Philosophy and Decolonizing Approaches the Life Sciences (especially psychedelic psychotherapy, genetics and stem cell research), and Science and Technology Studies.

David conducts psychopharmacological research, using brain-imaging techniques such as PET and MRI. He was trained in PET imaging at Columbia University in New York and later undertook a PhD at University Hospital Rigshospitalet in Copenhagen. Since 2009 he has been involved in post-doc imaging research into the neurobiology of addictions and major depression at Imperial. From early 2021 he’s been heading a new NHS-based research clinic at St Charles Hospital, the CIPPRes Clinic.

David Nutt is the Edmond J. Safra Professor of Neuropsychopharmacology and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences.  

David is Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary. He has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 27 books.

David broadcasts widely to the general public both on radio and television including BBC science and public affairs programmes on therapeutic as well as illicit drugs, their harms and their classification. 

Peter is an Anglo-Scandinavian philosopher of mind who specialises in the thought of Whitehead, Nietzsche, and Spinoza, and in fields pertaining to panpsychism and altered states of mind. 

Peter is the author of Noumenautics (2015), Modes of Sentience (2021), co-editor of Bloomsbury's Philosophy and Psychedelics (2022), the TEDx Talker on ‘psychedelics and consciousness‘, and he is inspiration to the inhuman philosopher Marvel Superhero, Karnak. He is creator, with Prof. Christine Hauskeller, of the Philosophy of Psychedelics Exeter Research Group.